Literature DB >> 9449695

Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

J B Rosenberg1, P A Foster, R J Kaufman, E A Vokac, M Moussalli, P A Kroner, R R Montgomery.   

Abstract

In plasma, von Willebrand factor (vWf) associates with Factor VIII (FVIII); however, the site at which these proteins first interact has not been defined. Administration of 1-desamino-8-D-arginine vasopressin (DDAVP) causes a rapid, concomitant elevation in plasma levels of both vWf and FVIII, suggesting the existence of a DDAVP-releasable storage pool for both proteins. To determine whether vWf and FVIII can associate intracellularly and colocalize to storage vesicles, we transfected AtT-20 cells with vWf and FVIII expression plasmids. FVIII alone was not detectable within storage granules; however, transfection of vWf cDNA into the same cell caused FVIII to alter its intracellular trafficking and to undergo granular storage, colocalizing to the vWf-containing granules. In contrast, colocalization of FVIII was not observed when these cells were transfected with plasmids encoding defective FVIII-binding vWf mutants. Transfection of bovine endothelial cells with FVIII further demonstrated vesicular storage of FVIII with vWf in Weibel-Palade bodies. Since gene therapy of hemophilia A may ultimately target endothelium or hematopoietic stem cells, the interaction between vWf and FVIII within a secretory cell is important. Thus, vWf can alter the intracellular trafficking of FVIII from a constitutive to a regulated secretory pathway, thereby producing an intracellular storage pool of both proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449695      PMCID: PMC508605          DOI: 10.1172/JCI1250

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.

Authors:  U M Vischer; D D Wagner
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

Review 2.  Sorting and processing of secretory proteins.

Authors:  P A Halban; J C Irminger
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

3.  von Willebrand factor: structure and function.

Authors:  D Meyer; J P Girma
Journal:  Thromb Haemost       Date:  1993-07-01       Impact factor: 5.249

Review 4.  Desmopressin (DDAVP) and hemostasis.

Authors:  S Lethagen
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

5.  Role of the B domain for factor VIII and factor V expression and function.

Authors:  D D Pittman; K A Marquette; R J Kaufman
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

6.  Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.

Authors:  D D Pittman; E M Alderman; K N Tomkinson; J H Wang; A R Giles; R J Kaufman
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

7.  Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.

Authors:  M Cattaneo; L Simoni; A Gringeri; P M Mannucci
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

8.  von Willebrand factor storage requires intact prosequence cleavage site.

Authors:  A M Journet; S Saffaripour; E M Cramer; D Tenza; D D Wagner
Journal:  Eur J Cell Biol       Date:  1993-02       Impact factor: 4.492

9.  Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.

Authors:  D A Michnick; D D Pittman; R J Wise; R J Kaufman
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

10.  Transplantation of spleen cells in patients with hemophilia A. A report of 20 cases.

Authors:  L Liu; S Xia; J Seifert
Journal:  Transpl Int       Date:  1994-05       Impact factor: 3.782

View more
  27 in total

Review 1.  Secretory pathways in endothelin synthesis.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  A revised model for the secretion of tPA and cytokines from cultured endothelial cells.

Authors:  Laura Knipe; Athinoula Meli; Lindsay Hewlett; Ruben Bierings; John Dempster; Paul Skehel; Matthew J Hannah; Tom Carter
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

3.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

Review 4.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

Review 5.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

6.  Origin of endothelial progenitors in human postnatal bone marrow.

Authors:  Morayma Reyes; Arkadiusz Dudek; Balkrishna Jahagirdar; Lisa Koodie; Paul H Marker; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 7.  Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors:  Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal:  Blood       Date:  2016-09-01       Impact factor: 22.113

8.  Alternative strategies for gene therapy of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

9.  Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.

Authors:  Qizhen Shi; David A Wilcox; Scot A Fahs; Hartmut Weiler; Clive W Wells; Brian C Cooley; Drashti Desai; Patricia A Morateck; Jack Gorski; Robert R Montgomery
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

10.  Mesenchymal stem cells contribute to endogenous FVIII:c production.

Authors:  Chad Sanada; Chung-Jung Kuo; Evan J Colletti; Melisa Soland; Saloomeh Mokhtari; Mary Ann Knovich; John Owen; Esmail D Zanjani; Christopher D Porada; Graça Almeida-Porada
Journal:  J Cell Physiol       Date:  2013-05       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.